Pre-matched cohort | Post-matched cohort | |||||||
---|---|---|---|---|---|---|---|---|
Total | DAAb | Watson-Jones | p value | Total | DAAb | Watson-Jones | p value | |
Number of patients | 1408 | 846 (60.0%) | 562 (39.9%) | 792 | 396 | 396 | ||
Age (years) | 68.9 (± 10.4) | 67.4 (± 10.3) | 71.4 (± 10) | < 0.001 | 68.7 (± 10.3) | 67.3 (±10.3) | 68.5 (±10.2) | 0.198 |
BMIa | 27.8 ± (4.8) | 27.2 (± 4.9) | 28.7 (± 5.5) | < 0.001 | 28.1 (± 4.9) | 27.7 (±4.7) | 27.6 (±4.9) | 0.245 |
Female | 811 (57.5%) | 476 (56.3%) | 335 (59.5%) | 0.214 | 486 (61%) | 243 (61.3%) | 243 (61.3%) | 0.382 |
ASA** I | 98 (6.9%) | 78 (9.2%) | 20 (3.6%) | 40 (5.0%) | 24 (6.1%) | 16 (4.0%) | ||
ASA** II | 934 (66.3%) | 603 (71.2%) | 331 (58.9%) | 568 (71.2%) | 284 (71.7%) | 284 (71.7%) | ||
ASA** III | 374 (26.5%) | 164 (19.3%) | 210 (37.3%) | < 0.001 | 184 (23.2%) | 88 (22.22%) | 96 (24.2%) | 0.175 |
ASA** IV | 2 (0.1%) | 1 (0.1%) | 1 (0.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |